Immunotherapy in Cancer Clinical Oncology Society 2017
See what other conferences are available at www.browse.armchairmedical.tv
-
Treating melanoma in non-trial populations Alexander Menzies
-
Systematic approaches to reduce time to implementation Nicole Rankin
-
Moffitt clinical pathways translating evidence into standardized practice Dana Rollison
-
The role of inspiration, perspiration and evidence in research translation Christine Paul
-
A framework for de-intensification of cancer screening programs Alexandra Barratt
-
Melanoma MDT panel discussion Chair Alexander Menzies
-
MDT panel discussion Chair Nick Pavlakis Co-Chair Alexander Menzies
-
Exercise and Immunotherapy Michael Marthick
-
The intestinal microbiome, chemotherapy and adjuvant treatments with probiotics Prof Luis Vitetta
-
An integrative model of wellness & supportive care at ONJ Cancer Centre Penelope Sanderson
-
Supportive and palliative care Holistic supportive care for patient receiving immunotherapy Judith Lacey
-
Living well with immunotherapies - the patient perspective Karen van Gorp
-
Uncertainty in immunotherapy raises the question what is the GP role in primary cancer treatment Prof Geoffrey Mitchell
-
My Story Ian Cant
-
When am I a survivor changing perspectives on metastatic cancer and its impact on cancer nursing Mei Krishnasamy
-
The experience of patients receiving pembrolizumab therapy for metastatic melanoma Living in uncertain spaces Haryana Dhillon
-
Uncertainty in the age of immunotherapy Surviving against the odds Panel Discussion
-
Digital Guidelines - an International Perspective Jutta Thwaites
-
Challenges of writing new guidelines prof Phyllis Butow
-
Chemotherapy Guidelines and Controversy. The safe delivery of cancer therapy Christine Carrington
-
Using Education to Disseminate and implement Guidelines Ian N Olver
-
Guidelines Panel Discussion
-
Hot Topic Discussion Cancer services are leading the way in health services reform
-
COSA Presidential Lecture Lessons from QF 32 Captain Richard De Crespigny
